These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6344545)

  • 21. Is prostaglandin F2 alpha involved in the increased myometrial contractility of primary dysmenorrhoea?
    Lumsden MA; Kelly RW; Baird DT
    Prostaglandins; 1983 May; 25(5):683-92. PubMed ID: 6577521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What regulates placental steroidogenesis in 90-day pregnant ewes?
    Weems YS; Kim L; Tsuda V; Yin C; Weems CW
    Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes of prostaglandin receptors in myometrium--interaction between steroids and prostaglandins--(author's transl)].
    Imoto N; Ninagawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):749-56. PubMed ID: 6264002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dysmenorrhea induced by lumbosacral spine disorders. Pathogenesis, diagnosis and therapy with special emphasis on spinal manipulative therapy].
    Grgić V
    Lijec Vjesn; 2009; 131(9-10):275-9. PubMed ID: 20030292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of uterine activity by prostaglandin synthetase inhibitors.
    Pulkkinen MO
    Acta Obstet Gynecol Scand Suppl; 1979; 87():39-43. PubMed ID: 111465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhea.
    Akerlund M
    Prog Brain Res; 2002; 139():359-65. PubMed ID: 12436949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An in vivo mouse model of primary dysmenorrhea.
    Yang L; Cao Z; Yu B; Chai C
    Exp Anim; 2015; 64(3):295-303. PubMed ID: 25912320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemistry of myometrial contractility.
    Egarter CH; Husslein P
    Baillieres Clin Obstet Gynaecol; 1992 Dec; 6(4):755-69. PubMed ID: 1335853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium antagonists and dysmenorrhea.
    Andersson KE
    Ann N Y Acad Sci; 1988; 522():747-56. PubMed ID: 3288067
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative study of the effect of high-intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea.
    Milsom I; Hedner N; Mannheimer C
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):123-9. PubMed ID: 8296814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The presence of leukotriene C4- and prostacyclin-binding sites in nonpregnant human uterine tissue.
    Chegini N; Rao CV
    J Clin Endocrinol Metab; 1988 Jan; 66(1):76-87. PubMed ID: 2826530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary dysmenorrhea.
    Abraham GE
    Clin Obstet Gynecol; 1978 Mar; 21(1):139-45. PubMed ID: 630748
    [No Abstract]   [Full Text] [Related]  

  • 33. Vascularization of human endometrium. Uterine blood flow in healthy condition and in primary dysmenorrhoea.
    Akerlund M
    Ann N Y Acad Sci; 1994 Sep; 734():47-56. PubMed ID: 7978951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracts of compound Muniziqi granule suppressed uterus contraction and ameliorated oxytocin-induced primary dysmenorrhea.
    Wei Y; Ma T; Wang H; Xing J; Wang Y; Gu Z; Mu D; Yin Q; Cheng X; Wang C
    J Ethnopharmacol; 2018 Sep; 223():33-40. PubMed ID: 29783015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary dysmenorrhea: current insights in etiology and treatment].
    Hein PR; Eskes TK
    Ned Tijdschr Geneeskd; 1984 Jan; 128(2):73-8. PubMed ID: 6422313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The patterns of uterine contractility in normal menstruating women: from physiology to pathology.
    Bulletti C; DE Ziegler D; Setti PL; Cicinelli E; Polli V; Flamigni C
    Ann N Y Acad Sci; 2004 Dec; 1034():64-83. PubMed ID: 15731300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in hormone levels and gap junctions in the rat uterus during pregnancy and parturition.
    Puri CP; Garfield RE
    Biol Reprod; 1982 Nov; 27(4):967-75. PubMed ID: 6959654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility.
    Lundström V; Gréen K; Svanborg K
    Acta Obstet Gynecol Scand Suppl; 1979; 87():51-6. PubMed ID: 111466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of progesterone, prostaglandin F2alpha and oxytocin on the calcium-activation of the uterus.
    Torok I; Csapo AI
    Prostaglandins; 1976 Aug; 12(2):253-69. PubMed ID: 959590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prostaglandin inhibition on vasopressin levels in women with primary dysmenorrhea.
    Strömberg P; Forsling ML; Akerlund M
    Obstet Gynecol; 1981 Aug; 58(2):206-8. PubMed ID: 7254732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.